back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-06 16:18 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
4,070,000 | |
| Filed 2024-03-28 16:37 Tx date 2024-03-26 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
3,070,000 | |
| Filed 2023-05-24 12:45 Tx date 2023-05-24 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,968
+69,000 vol $0.072 each |
6,778,689 | |
| Filed 2023-04-07 01:31 Tx date 2023-04-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$75,000
+1,000,000 vol $0.075 each |
2,070,000 | |
| Filed 2023-04-07 01:22 Tx date 2023-03-31 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
46 - Compensation for services
|
$75,000
+1,000,000 vol $0.075 each |
||
| Filed 2022-01-20 13:25 Tx date 2021-12-31 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-1,214,377 vol |
6,409,689 | |
| Filed 2022-01-19 11:34 Tx date 2022-01-18 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$40,500
+300,000 vol $0.135 each |
7,924,066 | |
| Filed 2021-04-06 12:13 Tx date 2021-04-01 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+300,000 vol $0.175 each |
1,070,000 | |
| Filed 2020-03-09 17:53 Tx date 2020-01-20 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+450,000 vol $0.10 each |
770,000 | |
| Filed 2020-03-09 14:20 Tx date 2020-02-11 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+450,000 vol $0.10 each |
||
| Filed 2020-03-09 14:20 Tx date 2020-02-11 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+450,000 vol $0.10 each |
770,000 | |
| Filed 2020-02-13 17:44 Tx date 2020-01-20 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+450,000 vol $0.10 each |
||
| Filed 2020-02-13 17:44 Tx date 2020-01-20 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+450,000 vol $0.10 each |
||
| Filed 2020-02-18 21:22 Tx date 2020-02-18 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,500
-25,000 vol $0.10 each |
7,624,066 | |
| Filed 2020-02-13 17:56 Tx date 2020-02-11 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$15,892
+211,899 vol $0.075 each |
7,649,066 | |
| Filed 2020-02-13 17:48 Tx date 2020-02-11 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
46 - Compensation for services
|
+211,899 vol |
378,566 | |
| Filed 2020-02-13 17:44 Tx date 2020-01-20 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+450,000 vol $0.10 each |
770,000 | |
| Filed 2020-02-13 12:42 Tx date 2020-02-11 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
46 - Compensation for services
|
$15,892
+211,899 vol $0.075 each |
||
| Filed 2020-02-13 12:33 Tx date 2020-02-11 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
46 - Compensation for services
|
$15,892
+211,899 vol $0.075 each |
||
| Filed 2020-02-13 12:27 Tx date 2020-02-11 |
$VM
Voyageur Pharmaceuticals Ltd. (formerly Voyageur Minerals Ltd.) |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$15,892
+211,899 vol $0.075 each |